You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

PR Negative Breast Cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

TNBC - Triple-Negative Breast Cancer Trial (Alkaline Glucosodiene Molecules)

Not yet recruiting
  • TNBC - Triple-Negative Breast Cancer
  • Alkaline Glucosodiene Molecules
  • (no location specified)
Jul 14, 2023

Invasive Breast Cancer, Triple Negative Breast Cancer, ER-Negative Breast Cancer Trial in Boston, Danvers, Newton (Sacituzumab

Active, not recruiting
  • Invasive Breast Cancer
  • +4 more
  • Boston, Massachusetts
  • +4 more
Oct 25, 2021

HER2-positive Breast Cancer Trial in China (TQB2440 injection + Trastuzumab + Docetaxel, Perjeta + Trastuzumab + Docetaxel)

Active, not recruiting
  • HER2-positive Breast Cancer
  • TQB2440 injection + Trastuzumab + Docetaxel
  • Perjeta + Trastuzumab + Docetaxel
  • Chongqing, Chongqing, China
  • +5 more
Aug 3, 2023

Metastatic Triple Negative Breast Cancer Trial in Birmingham (Combination of Veliparib + Lapatinib)

Active, not recruiting
  • Metastatic Triple Negative Breast Cancer
  • Combination of Veliparib + Lapatinib
  • Birmingham, Alabama
    University of Alabama at Birmingham
Feb 25, 2022

Anatomic Stage I Breast Cancer AJCC v8, Anatomic Stage IA Breast Cancer AJCC v8, Anatomic Stage IB Breast Cancer AJCC v8 Trial

Suspended
  • Anatomic Stage I Breast Cancer AJCC v8
  • +23 more
  • Short-Term Fasting
  • Chemotherapy
  • Philadelphia, Pennsylvania
    Sidney Kimmel Cancer Center at Thomas Jefferson University
Jan 23, 2023

Breast Cancer, HER2-negative Breast Cancer, ER Positive Breast Cancer Trial in Stanford (Infigratinib, Tamoxifen, Omnipaque 350)

Recruiting
  • Breast Cancer
  • +3 more
  • Stanford, California
    Stanford University
Feb 16, 2022

Breast Cancer Trial in United States (bicalutamide, diagnostic laboratory biomarker analysis, immunohistochemistry staining

Completed
Has Results
  • Breast Cancer
  • San Francisco, California
  • +7 more
Jul 8, 2022

Stage IV (Metastatic) Breast Cancer, Metastatic Breast Cancer, ER Positive Breast Cancer Trial in Boston (NERATINIB,

Not yet recruiting
  • Stage IV (Metastatic) Breast Cancer
  • +5 more
  • Boston, Massachusetts
    Massachusetts General Hospital
Oct 25, 2021

After Neoadjuvant Chemotherapy for Breast Cancer

Recruiting
  • TN ER-/PR-/HER2- Breast Cancer
  • +3 more
  • Standard Trimodality Breast Imaging
  • Minneapolis, Minnesota
    University of Minnesota Masonic Cancer Center
Aug 13, 2021

Estrogen Receptor-negative Breast Cancer, HER2-negative Breast Cancer, Progesterone Receptor-negative Breast Cancer Trial in New

Suspended
  • Estrogen Receptor-negative Breast Cancer
  • +8 more
  • pegylated liposomal doxorubicin hydrochloride
  • +6 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Sep 20, 2021

HER2-positive Breast Cancer, ER-Negative Breast Cancer, PR-Negative Breast Cancer Trial in Belgium, France (Pertuzumab and

Recruiting
  • HER2-positive Breast Cancer
  • +3 more
  • Pertuzumab and tratuzumab fixed dose combination
  • Trastuzumab emtansine
  • Auchenflower, Australia
  • +84 more
Jan 16, 2023

Breast Cancer Trial in Brazil (No axillary surgery, SLNB)

Recruiting
  • Breast Cancer
  • No axillary surgery
  • SLNB
  • Fortaleza, CE, Brazil
  • +13 more
Apr 6, 2022

Metastatic Breast Cancer Trial in Athens

Recruiting
  • Metastatic Breast Cancer
    • Athens, Greece
      Hellenic Society of Medical Oncology
    Feb 9, 2021

    Breast Cancer, Invasive Breast Cancer, ER-Negative PR-Negative HER2-Negative Breast Cancer Trial in Chapel Hill (Entinostat)

    Terminated
    • Breast Cancer
    • +2 more
    • Chapel Hill, North Carolina
      Lineberger Comprehensive Cancer Center at University of North Ca
    Mar 22, 2021

    Breast Cancer Trial in Xi'an (metronomic oral vinorelbine plus anlotinib)

    Recruiting
    • Breast Cancer
    • metronomic oral vinorelbine plus anlotinib
    • Xi'an, Shaanxi, China
      Xi'an International Medical Center Hospital
    Aug 27, 2023

    Metastatic Triple-Negative Breast Cancer Trial in Charlotte (Trilaciclib, Pembrolizumab, Gemcitabine)

    Not yet recruiting
    • Metastatic Triple-Negative Breast Cancer
    • Charlotte, North Carolina
      Levine Cancer Institute
    Aug 31, 2023

    TNBC - Triple-Negative Breast Cancer Trial in Nanjing (Fluzoparib+Paclitaxel, Epirubicin+Cyclophosphamide)

    Recruiting
    • TNBC - Triple-Negative Breast Cancer
    • Nanjing, Jiangsu, China
      JiangSu Province Hospital/ The First Affiliated Hospital of Nanj
    Apr 27, 2023

    Triple Negative Breast Cancer, Metastatic Breast Cancer, Mutation Trial in Shanghai (Everolimus, Investigator's Choice of

    Not yet recruiting
    • Triple Negative Breast Cancer
    • +2 more
    • Shanghai, Shanghai, China
      Fudan University Shanghai Cancer Center
    Jul 25, 2023

    Breast Tumors Trial in Guangzhou (Trilaciclib, Epirubicin, Cyclophosphamide)

    Not yet recruiting
    • Breast Neoplasms
    • Guangzhou, Gangdong, China
      Sun-yat sen university cancer center
    Jul 30, 2023

    Triple Negative Breast Cancer Trial (Proleukin 1.3 MG Injection)

    Not yet recruiting
    • Triple Negative Breast Cancer
    • Proleukin 1.3 MG Injection
    • (no location specified)
    Apr 6, 2023

    Breast Cancer Trial in Shanghai, Tianjin (Trastuzumab, QL1209, Pertuzumab)

    Unknown status
    • Breast Cancer
    • Shanghai, Shanghai, China
    • +1 more
    Nov 10, 2020

    Breast Cancer Trial in United States (Low dose FRa vaccine, Cyclophosphamide, High dose FRa vaccine)

    Completed
    • Breast Cancer
    • Low dose FRα vaccine
    • +2 more
    • Tampa, Florida
    • +10 more
    Jul 15, 2021

    Triple-Negative Breast Cancer Trial in Shanghai (Trastuzumab Deruxtecan)

    Not yet recruiting
    • Triple-Negative Breast Cancer
    • Trastuzumab Deruxtecan
    • Shanghai, Shanghai, China
      Breast cancer institute of Fudan University Cancer Hospital
    Jul 12, 2023

    Breast Tumors Trial in Hangzhou (Sindilimab, Nab-paclitaxel, Lenvatinib)

    Not yet recruiting
    • Breast Neoplasms
    • Hangzhou, Zhejiang, China
      ZhejiangCH
    Nov 17, 2023

    Breast Cancer Trial in Sydney ([68Ga]GA-NeoB)

    Recruiting
    • Breast Cancer
    • Sydney, New South Wales, Australia
      St Vincent's Hospital
    May 22, 2023